Invenomic Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14.3M	Buy	8,294,663 +2,804,864	+51%	+$4.82M	0.81%	46
2025 Q1	$18.3M	Buy	+5,489,799	New	+$18.3M	0.92%	30
2024 Q1	–	Sell	-1,053,251	Closed	-$8.56M	–	164
2023 Q4	$8.56M	Buy	+1,053,251	New	+$8.56M	0.39%	71